NCT07323810

Brief Summary

Mental fatigue (MF) negatively affects both cognitive and physical performance, increasing the risk of errors in high-stakes environments such as sports and surgery. Traditional methods to assess MF rely on subjective self-report scales, which are prone to bias, or on complex brain measurements (e.g. EEG) that are impractical outside laboratory settings. This study aims to develop a real-time, objective monitoring method for MF using wearable physiological sensors. The study will recruit healthy, trained runners (18-35 years old) who will complete both an MF-inducing cognitive task (Stroop test) and a control condition (watching a documentary) in a randomized, counterbalanced, crossover design. Heart rate variability, respiration rate, and pupil metrics will be continuously recorded using wearable devices. Machine learning models will be used to predict MF-level as well as the effect of MF on physical performance (5-km time trial on a treadmill) using the physiological data as input.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Jan 2026Jun 2026

First Submitted

Initial submission to the registry

August 22, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

January 7, 2026

Status Verified

August 1, 2025

Enrollment Period

5 months

First QC Date

August 22, 2025

Last Update Submit

December 22, 2025

Conditions

Keywords

FatiguePerformancePhysiologyWearables

Outcome Measures

Primary Outcomes (9)

  • Heart rate variability time-domain parameters

    Root mean square of successive differences \[RMSSD\], standard deviation of normal-to-normal intervals \[SDNN\] in milliseconds.

    Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  • Heart rate variability frequency-domain parameters

    Low-frequency (LF), High-frequency (HF) in milliseconds squared (ms²) and Low/high-frequency ratio \[LF/HF\]

    Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  • Respiration rate

    Respiration rate (RR) will be measured as the number of breaths per minute (breaths/min)

    Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  • Pupil diameter

    Pupil diameter (PD) will be measured in millimeters (mm) as an index of autonomic nervous system activity.

    Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  • Blinking rate

    Blinking rate (BR) will be measured as the number of spontaneous blinks per minute (blinks/min)

    Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  • Eyelid opening

    Eyelid opening (EO) will be measured as the vertical distance between the upper and lower eyelid in millimeters (mm).

    Continuously during the cognitive intervention and control condition on the study day (approximately 75 minutes).

  • Cognitive Performance Accuracy

    Cognitive performance will be evaluated using a Go/No-Go task. The task begins with a general instruction screen, followed by the simultaneous presentation of two types of stimuli: a Go or No-Go signal and a left or right directional indicator. This results in four possible combinations: GoRight, GoLeft, NoGoRight, and NoGoLeft. When a Go signal appears, participants must respond by pressing the arrow key corresponding to the left or right direction. In contrast, when a No-Go signal is displayed, participants must withhold any response, regardless of the directional cue. This paradigm is designed to assess attention, response inhibition, working memory, and executive functions, all of which are known to be negatively affected by MF. Accuracy in percentage (%) of correct answers on this Go/No-Go task as well as accuracy during the Stroop intervention task will be measured.

    At baseline (pre-intervention), during the 60-minute cognitive intervention, and immediately after completion of the intervention on the study day (approximately 70 minutes total).

  • Cognitive Performance Reaction Time

    Cognitive performance will be evaluated using a Go/No-Go task. The task begins with a general instruction screen, followed by the simultaneous presentation of two types of stimuli: a Go or No-Go signal and a left or right directional indicator. This results in four possible combinations: GoRight, GoLeft, NoGoRight, and NoGoLeft. When a Go signal appears, participants must respond by pressing the arrow key corresponding to the left or right direction. In contrast, when a No-Go signal is displayed, participants must withhold any response, regardless of the directional cue. This paradigm is designed to assess attention, response inhibition, working memory, and executive functions, all of which are known to be negatively affected by MF. Reaction time (RT) will be measured in milliseconds (ms) as the latency between stimulus onset and the participant's behavioral response (button press) on the Go/No-Go task and during the Stroop intervention task.

    At baseline (pre-intervention), during the 60-minute cognitive intervention, and immediately after completion of the intervention on the study day (approximately 70 minutes total).

  • Physical performance: Time to Completion

    Participants will perform a 5-km running time trial on a treadmill to assess endurance performance under MF. The treadmill will be set at a 1% gradient, following established protocols to replicate outdoor running conditions. Before beginning the time trial, participants will complete a standardized warm-up for 5 minutes. To maintain self-paced running conditions, participants will receive real-time feedback on the distance covered but will not be provided with information about running speed or elapsed time. Researchers will remain present but will not offer verbal encouragement or pacing cues to ensure that the effort remains internally regulated. Once the 5-km distance is completed, participants will immediately stop running and step onto the treadmill's side platforms. The total time elapsed will be recorded.

    Immediately after completion of the 60-minute cognitive intervention, during a single 5-km treadmill time trial on the study day (approximately 20 minutes).

Secondary Outcomes (7)

  • Subjective feeling of Mental Fatigue

    At baseline (pre-intervention), every 5 minutes during the 60-minute cognitive intervention, and immediately after completion of the intervention on the study day.

  • Mood

    At baseline, prior to the start of each experimental and control trial on the study day.

  • Motivation

    At baseline (pre-intervention) and immediately after completion of the 60-minute cognitive intervention on the study day.

  • Sleepiness

    At baseline (pre-intervention) and immediately after completion of the 60-minute cognitive intervention on the study day.

  • Physical fatigue

    Immediately prior to the physical performance test on the study day.

  • +2 more secondary outcomes

Study Arms (2)

Mental Fatigue Condition

EXPERIMENTAL

The mental fatigue task will involve a modified Stroop test, adapted from previous research. Words will appear on the screen in 34-point font for 1000 milliseconds, with the inter-stimulus interval personalized based on each participant's Stroop max test performance. Stroop task duration will be 60 minutes for every participant. Participants will be instructed to respond as quickly and accurately as possible.

Behavioral: Mental Fatigue

Control condition

NO INTERVENTION

The control task will consist of watching a pre-approved, emotionally neutral 60-minute documentary.

Interventions

Mental FatigueBEHAVIORAL

Mental fatigue (MF) is a psychobiological state characterized by feelings of tiredness and/or a measurable decline in performance following prolonged or intense cognitive activity.

Mental Fatigue Condition

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy (no neurological, cardiovascular or musculoskeletal disorders of any kind)
  • Male or female
  • No prior knowledge of the concept of MF
  • No medication
  • Non-smoker
  • years of age
  • Experienced runners: (≥15km/week and/or ≥2u/week during the last 6 months)

You may not qualify if:

  • Injuries in the past 6 months, affecting running performance
  • Suffering from a chronic health condition (could be neurological, cardiovascular, internal or musculoskeletal)
  • Participating in any concomitant care or research trials
  • History of suffering from any mental/psychiatric disorders
  • Use of medication
  • Use of caffeine and heavy efforts 24 hours prior each trial
  • Suffering from colour vision deficiencies
  • Not eating a standardized meal, the morning of each trial and the evening before each trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brussels Labo voor Inspanning en Topsport

Brussels, 1050, Belgium

RECRUITING

MeSH Terms

Conditions

Mental FatigueFatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Central Study Contacts

Emilie Schampheleer, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Doctor

Study Record Dates

First Submitted

August 22, 2025

First Posted

January 7, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

January 7, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations